Patient-reported outcome (Qol, fatigue, sleep, cognition, anxiety, depression) in cooperation with Prof. R. Schlenk

  • SarcBOP “A prospective Registry Study on Biological Disease Profile, Intervention Type and Clinical Outcome in Patients with Soft-tissue and Bone Sarcoma”
    In cooperation with Prof. Dr. Richard Schlenk, National Center for Tumor Diseases (NCT), Heidelberg

  • Q-HAM “Quizartinib and High-dose Ara-C plus Mitoxantrone in Relapsed/Refractory AML with FLT3-ITD”
    Phase II clinical trial In cooperation with Prof. Dr. Richard Schlenk, National Center for Tumor Diseases (NCT), Heidelberg and the Medical University of Heidelberg

  • MyBOP „A prospective Registry Study on Biological Disease Profile, Intervention Type and Clinical Outcome in Patients with Myeloid Neoplasms“
    In cooperation with Prof. Dr. Richard Schlenk, National Center for Tumor Diseases (NCT), Heidelberg

to top
powered by webEdition CMS